Helicobacter Pylori Diagnostics Market

Helicobacter Pylori Diagnostics Market by Technology (Immunoassays, POC, and Molecular Diagnostics), End-users (Hospitals, Diagnostics Laboratories, and Clinics), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-885
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 176
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global helicobacter pylori diagnostics market size is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the improved cost-effectiveness of diagnosis of infection and rising demand for personalized antibiotic therapy.
 

Helicobacter Pylori Diagnostics Market Key Takeaways


Helicobacter pylori, also known as an aerobic gram-negative bacteria, is commonly found in stomach. Although stomach ecology is balanced by this bacteria, still it can cause infection to the inner stomach lining. The bacteria acts as a causative agent for gastric ulcers, gastritis, stomach cancer, infection in the small intestine, and duodenal ulcers. This generates demand for diagnostic methods for helicobacter pylori infection. In case of positive diagnosis of ulcers, antibiotic treatment is generally given to patients for 10 to 14 days.

In 1994, the International Agency for Research on Cancer categorized helicobacter pylori as a carcinogen. Although the exact mode of transmission of this infection remains uncertain, it is suggested that the infection can be transmitted from one person to other through fecal-oral route. The helicobacter pylori infection, which is mostly seen in childhood has no any specific symptoms. This infection is highly prevalent in developing nations due to some major factors such as dense population, lack of water supply, poor personal hygiene, and poor sanitation.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising awareness about the infection and growing governments’ programs for the healthcare development especially in developing countries are key factors responsible for driving market growth.
  • Availability of personalized antibiotic treatment, affordable, and cost-effective diagnosis are drivers for the helicobacter pylori diagnostics market.
  • Rapid development of advanced technology for diagnostics and rising preference for early detection of the infection are major factors boosting the market growth.
  • Easy accessibility of point-of-care testing as well as availability of several invasive and non-invasive devices are anticipated to propel the growth of the market.
  • Lack of awareness about benefits of the testing and unavailability of skilled professionals are projected to hamper the market growth.

Scope of the Report

The report on the global helicobacter pylori diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Helicobacter Pylori Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Technology (Immunoassays, POC, and Molecular Diagnostics) and End-users (Hospitals, Diagnostics Laboratories, and Clinics)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Thermo Fisher Scientific; Biohit; Quest Diagnostics; Meridian Bioscience; Bio-Rad Laboratories; Alpha Laboratories; F. Hoffmann-La Roche; Coris BioConcept; Certest Biotec; and Epitope Diagnostics

 

Helicobacter Pylori Diagnostics Market Segment Insights

Immunoassay segment to account for a key share
Based on technology, the global helicobacter pylori diagnostics market is divided into immunoassays, POC, and molecular diagnostics. The immunoassay segment accounted for a large market share in 2019 and is projected to expand at a rapid growth rate during the forecast period. For detecting of antibodies, many technologies are used and the enzyme immunoassays is one of the most widely adopted technology for the same purpose. On the other hand, the POC segment is expected to register substantial growth during the forecast period owing to wide adoption of the technique for helicobacter pylori diagnostics. Meanwhile, the molecular diagnostics accounted for the second largest market share in 2019 due to its high accuracy and improved testing result.

Hospitals segment to hold a major market share
On the basis of end-users, the market is divided into hospitals, diagnostics laboratories, and clinics. In 2019, the hospitals segment held a major market share and the trend is likely to continue during the forecast period. The segment growth can be attributed to ease of accessibility of doctors and medical staffs who are expert in disease presentation of related diseases such as gastritis, infections to small intestine, duodenal ulcers, gastric ulcers, and stomach cancer.

The diagnostic laboratories segment, however, is anticipated to show a fast CAGR during the forecast period owing to efficient and specialized detection of infection in the specialized laboratories. Moreover, the rising adoption of the testing process of the infection in diagnostic laboratories in a search of finding advanced drugs and techniques for the treatment present another key driver for the segment growth. In 2019, the combined share of hospitals and diagnostics laboratories represented more than 80% share of the total market.

North America is projected to exhibit a robust CAGR
In terms of regions, the global helicobacter pylori diagnostics market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2019 and is projected to exhibit a robust CAGR during the forecast period owing to better economy and healthcare infrastructural development. Moreover, the presence of key global players in the region especially in the US is another crucial factor for the regional market expansion. On the other hand, the market in Asia Pacific is anticipated to register a fast CAGR during the forecast period owing to increasing rate of population growth and rising occurrence of helicobacter pylori infections in the region.
 

Helicobacter Pylori Diagnostics Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Helicobacter Pylori Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Helicobacter Pylori Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Helicobacter Pylori Diagnostics Market - Supply Chain
  4.5. Global Helicobacter Pylori Diagnostics Market Forecast
     4.5.1. Helicobacter Pylori Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Helicobacter Pylori Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Helicobacter Pylori Diagnostics Market Absolute $ Opportunity
5. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
     5.3.1. Hospitals
     5.3.2. Diagnostics Laboratories
     5.3.3. Clinics
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Helicobacter Pylori Diagnostics Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
7. North America Helicobacter Pylori Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
     7.4.1. Hospitals
     7.4.2. Diagnostics Laboratories
     7.4.3. Clinics
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Helicobacter Pylori Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
     8.4.1. Hospitals
     8.4.2. Diagnostics Laboratories
     8.4.3. Clinics
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
9. Europe Helicobacter Pylori Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
     9.4.1. Hospitals
     9.4.2. Diagnostics Laboratories
     9.4.3. Clinics
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Helicobacter Pylori Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
     10.4.1. Hospitals
     10.4.2. Diagnostics Laboratories
     10.4.3. Clinics
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Helicobacter Pylori Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Helicobacter Pylori Diagnostics Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Helicobacter Pylori Diagnostics Market Size and Volume Forecast by End Users
     11.4.1. Hospitals
     11.4.2. Diagnostics Laboratories
     11.4.3. Clinics
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Helicobacter Pylori Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Helicobacter Pylori Diagnostics Market: Market Share Analysis
  12.2. Helicobacter Pylori Diagnostics Distributors and Customers
  12.3. Helicobacter Pylori Diagnostics Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Thermo Fisher Scientific
     12.4.2. Biohit, Quest Diagnostics
     12.4.3. Meridian Bioscience
     12.4.4. Bio-Rad Laboratories
     12.4.5. Alpha Laboratories

Segments Covered in the Report
The global helicobacter pylori diagnostics market has been segmented on the basis of

Technology

  • Immunoassays
  • POC
  • Molecular Diagnostics

End-users

  • Hospitals
  • Diagnostics Laboratories
  • Clinics

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Thermo Fisher Scientific
  • Biohit, Quest Diagnostics
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Alpha Laboratories
  • F. Hoffmann-La Roche
  • Coris BioConcept
  • Certest Biotec
  • Epitope Diagnostics


 

Some of the key players competing in the market are Thermo Fisher Scientific, Biohit, Quest Diagnostics, Meridian Bioscience, Bio-Rad Laboratories, Alpha Laboratories, F. Hoffmann-La Roche, Coris BioConcept, Certest Biotec, and Epitope Diagnostics.

These three major players such as Bio-Rad Laboratories, Quest Diagnostics, and Thermo Fisher Scientific accounted for a highest share of market in 2019 owing to wider geographical presence and broad product portfolio. The key players are constantly adopting many strategies such as mergers and acquisitions, regional expansions, strategic partnerships, and new product development to expand their market positions.

 

Helicobacter Pylori Diagnostics Market By key Players

Buy Report